Kinarus Therapeutics Holding AG
SIX:KNRS

Watchlist Manager
Kinarus Therapeutics Holding AG Logo
Kinarus Therapeutics Holding AG
SIX:KNRS
Watchlist
Price: 15 CHF 416 566.67% Market Closed
Market Cap: 19.5B CHF
Have any thoughts about
Kinarus Therapeutics Holding AG?
Write Note

Income Statement

Earnings Waterfall
Kinarus Therapeutics Holding AG

Revenue
0 CHF
Operating Expenses
-13.9m CHF
Operating Income
-13.9m CHF
Other Expenses
-6k CHF
Net Income
-13.9m CHF

Income Statement
Kinarus Therapeutics Holding AG

Rotate your device to view
Income Statement
Currency: CHF
Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023
Revenue
Revenue
4
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Gross Profit
Cost of Revenue
(4)
0
0
0
0
0
Gross Profit
1
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Operating Income
Operating Expenses
(1)
(0)
(1)
(2)
(3)
(14)
Selling, General & Administrative
(1)
(0)
(1)
(41)
(42)
(14)
Research & Development
0
0
(0)
(2)
(2)
0
Depreciation & Amortization
(0)
0
(0)
(2)
(2)
0
Other Operating Expenses
0
0
0
41
41
(0)
Operating Income
(1)
N/A
(0)
+48%
(1)
-179%
(2)
-110%
(3)
-40%
(14)
-312%
Pre-Tax Income
Interest Income Expense
1
0
0
(0)
(0)
(0)
Non-Reccuring Items
(1)
0
0
(38)
(38)
0
Pre-Tax Income
0
N/A
(0)
N/A
(1)
-617%
(41)
-3 855%
(42)
-3%
(14)
+67%
Net Income
Tax Provision
0
0
0
0
0
0
Income from Continuing Operations
0
(0)
(1)
(41)
(42)
(14)
Income to Minority Interest
0
0
0
0
(0)
0
Net Income (Common)
0
N/A
(0)
N/A
(1)
-579%
(41)
-4 079%
(42)
-3%
(14)
+67%
EPS (Diluted)
0
N/A
0
N/A
0
N/A
-0.04
N/A
-0.04
N/A
-0.01
+75%

See Also

Discover More